Therapeutic response
Showing 1 - 25 of >10,000
And Immuno-meDIated Adverse Events in Anti-cancer
Not yet recruiting
- Cancer
- (no location specified)
Jun 26, 2023
Metabolic Associated Fatty Liver Disease Trial (dapagliflozin (Forxiga))
Not yet recruiting
- Metabolic Associated Fatty Liver Disease
- dapagliflozin (Forxiga)
- (no location specified)
Mar 13, 2023
MAP THE SMA:Machine-learning Based Algorithm to Predict
Not yet recruiting
- Spinal Muscular Atrophy
- disease modifying treatments
- (no location specified)
Mar 14, 2023
Spinal Cord Stimulator Trial Period, Neuromodulation Trial Period, SCS Trial Period Trial in Augusta (external securement of scs
Recruiting
- Spinal Cord Stimulator Trial Period, Neuromodulation Trial Period, SCS Trial Period
- external securement of scs leads during the scs trial period
-
Augusta, GeorgiaAugusta University Health System Pain Clinic
Jul 13, 2023
SMN Circular RNAs as Potential Biomarkers for Therapeutic
Recruiting
- Spinal Muscular Atrophy
-
Rome, Italy/rome, Italyethics committee of IRCCS Fondazione Policlinico Gemelli
Mar 10, 2023
Pharmacological Action Trial (Rituximab, Dexamethasone)
Not yet recruiting
- Pharmacological Action
- (no location specified)
Sep 22, 2022
Elastography and Treatment of Lymphoma
Not yet recruiting
- Elastography
- Lymphoma
- (no location specified)
Jul 23, 2023
Immunoglobulin Light-chain Amyloidosis Trial (Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules
Not yet recruiting
- Immunoglobulin Light-chain Amyloidosis
- Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
- Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
- (no location specified)
Mar 18, 2023
Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)
Recruiting
- Glioblastoma
- +2 more
- TMZ
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Lung Cancer, Organoid, NSCLC Trial in Wuxi (Antitumor therapy guided by organoid drug sensitivity test)
Recruiting
- Lung Cancer
- +2 more
- Antitumor therapy guided by organoid drug sensitivity test
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of Jiangnan University
Feb 2, 2023
Urogenital Tumors, Drug Therapy Trial in Campinas (Biopsy)
Completed
- Urogenital Neoplasms
- Drug Therapy
- Biopsy
-
Campinas, SP, BrazilHospital das Clínicas Unicamp
Jul 7, 2022
Graves Ophthalmopathy Trial in Sofia (Orbital radiotherapy)
Completed
- Graves Ophthalmopathy
- Orbital radiotherapy
-
Sofia, BulgariaUniversity Hospital of Endocrinology
Mar 7, 2023
Alzheimer Trial in Toronto (tDCS and Cognitive Training)
Not yet recruiting
- Alzheimer Disease
- tDCS and Cognitive Training
-
Toronto, Ontario, CanadaBaycrest Health Sciences
Aug 19, 2022
First-episode Psychosis Trial in France (Recorded interview, Clinical scales, Blood sample)
Not yet recruiting
- First-episode Psychosis
- Recorded interview
- +3 more
-
Angers, France
- +5 more
Dec 29, 2022
Epigenetic Silencing of MicroRNA for Predicting Therapeutic
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Not interventional
-
Albuquerque, New MexicoUniversity of New Mexico - Cancer Center
Oct 4, 2022
Calcifediol in the Treatment of COVID 19
Completed
- COVID-19
- Calcifediol
- Best available therapy
-
Cordoba, Córdoba, SpainHospital Universitario Reina Sofia
Apr 17, 2023
ASCT Versus Chemotherapy as First-Line Consolidation Therapy
Completed
- T-cell Lymphoma Adults
- consolidation with ASCT
- (no location specified)
Nov 25, 2023
MDD Trial in France (escitalopram, vortioxetine)
Not yet recruiting
- Major Depressive Disorder
- escitalopram
- vortioxetine
-
La Tronche, Isère, France
- +4 more
May 10, 2023
SMN Circular RNAs as Potential New Targets and Biomarkers for
Recruiting
- Spinal Muscular Atrophy
-
Rome, ItalyPoliclinico gemelli
Feb 27, 2023
Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic
Not yet recruiting
- Hepatic Encephalopathy
- +2 more
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Jun 13, 2022
IL17 Rate and Spondyloarthritis
Recruiting
- Spondylarthritis
- Blood sample
-
Nice, FranceCHU de NICE
Oct 21, 2022
Melanoma Trial ([U-13C]Glucose Infusion)
Not yet recruiting
- Melanoma
- [U-13C]Glucose Infusion
- (no location specified)
Oct 6, 2022
Cytokines and Genes in Therapeutic Response in Crohn's Disease
Completed
- Inflammatory Bowel Diseases
- Baseline blood sample
- +6 more
-
Nashville, Tennessee
- +1 more
May 4, 2022
Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.
Recruiting
- Rheumatoid Arthritis
- +2 more
- Infliximab: Adalimumab; Etanercept;
-
Sulaymaniyah, Kurdistan Region, IraqHiwa Khidhir Saaed
May 12, 2022